EIX vs PPCB · P/E 7.3, rev $17.60B vs P/E 0.0, $3.9M cap
Edison International (EIX) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
PPCB does not have a complete income-statement cache yet.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the EIX and PPCB stock pages for the full models.
Not investment advice.